Kato M - Search Results

1

Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study.

Omura S, Kida T, Noma H, Sunaga A, Kusuoka H, Kadoya M, Nakagomi D, Abe Y, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Hirata S, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Yajima N, Kawaguchi T, Fukuda W, Kawahito Y. Omura S, et al. Among authors: kato m. Rheumatology (Oxford). 2023 Dec 1;62(12):3924-3931. doi: 10.1093/rheumatology/kead138. Rheumatology (Oxford). 2023. PMID: 36961329

2

Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome.

Ohnishi N, Fujieda Y, Hisada R, Nakamura H, Kato M, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Ohnishi N, et al. Among authors: kato m. Rheumatology (Oxford). 2019 Jun 1;58(6):969-974. doi: 10.1093/rheumatology/key340. Rheumatology (Oxford). 2019. PMID: 30508199 Free article.

3

Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus.

Hisada R, Kato M, Ohnishi N, Sugawara E, Fujieda Y, Oku K, Bohgaki T, Amengual O, Yasuda S, Atsumi T. Hisada R, et al. Among authors: kato m. Rheumatology (Oxford). 2019 Apr 1;58(4):645-649. doi: 10.1093/rheumatology/key365. Rheumatology (Oxford). 2019. PMID: 30521019

4

Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.

Kato M, Kaneko Y, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Nagasawa H, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Yokota I, Atsumi T, Takeuchi T. Kato M, et al. Mod Rheumatol. 2020 May;30(3):442-449. doi: 10.1080/14397595.2019.1621026. Epub 2019 Jun 7. Mod Rheumatol. 2020. PMID: 31106666 Free article. Clinical Trial.

5

Right ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertension.

Abe N, Kato M, Kono M, Fujieda Y, Ohira H, Tsujino I, Oyama-Manabe N, Oku K, Bohgaki T, Yasuda S, Atsumi T. Abe N, et al. Among authors: kato m. Rheumatology (Oxford). 2020 Mar 1;59(3):622-633. doi: 10.1093/rheumatology/kez336. Rheumatology (Oxford). 2020. PMID: 31424519 Free article.

6

Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositis.

Karino K, Kono M, Kono M, Sakamoto K, Fujieda Y, Kato M, Amengual O, Oku K, Yasuda S, Atsumi T. Karino K, et al. Among authors: kato m. Rheumatology (Oxford). 2020 Jul 1;59(7):1734-1742. doi: 10.1093/rheumatology/kez642. Rheumatology (Oxford). 2020. PMID: 31925431

7

Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study.

Ogata Y, Fujieda Y, Sugawara M, Sato T, Ohnishi N, Kono M, Kato M, Oku K, Amengual O, Atsumi T. Ogata Y, et al. Among authors: kato m. Rheumatology (Oxford). 2021 Mar 2;60(3):1331-1337. doi: 10.1093/rheumatology/keaa542. Rheumatology (Oxford). 2021. PMID: 32944779 Free article.

8

Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study.

Ninagawa K, Kato M, Tsuneta S, Ishizaka S, Ujiie H, Hisada R, Kono M, Fujieda Y, Ito YM, Atsumi T. Ninagawa K, et al. Among authors: kato m. Rheumatology (Oxford). 2023 Jul 5;62(7):2550-2555. doi: 10.1093/rheumatology/keac674. Rheumatology (Oxford). 2023. PMID: 36458921

9

Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 months.

Nagasaka K, Amano K, Dobashi H, Nagafuchi H, Sada KE, Komagata Y, Yamamura M, Kato M, Endo T, Nakaya I, Takeuchi T, Murakawa Y, Sugihara T, Saito M, Hayashi T, Furuta S, Tamura N, Karasawa K, Banno S, Endo S, Majima M, Kaname S, Arimura Y, Harigai M. Nagasaka K, et al. Among authors: kato m. Mod Rheumatol. 2023 Nov 1;33(6):1117-1124. doi: 10.1093/mr/roac150. Mod Rheumatol. 2023. PMID: 36478050

10

Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: reply.

Kato M, Ninagawa K, Atsumi T. Kato M, et al. Rheumatology (Oxford). 2023 Sep 1;62(9):e278-e279. doi: 10.1093/rheumatology/kead037. Rheumatology (Oxford). 2023. PMID: 36707999 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,101 results

Search Page